Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

Broth microdilution MICs were determined for 258 clinical isolates of Mycobacterium fortuitum (3 biovariants) and M. chelonae (2 subspecies) with amikacin, tobramycin, cefoxitin, doxycycline, erythromycin, and sulfamethoxazole-trimethoprim and with several new beta-lactams and aminoglycosides and ciprofloxacin. Variations in susceptibility by and within species subgroups confirm the need for susceptibility testing against clinically important strains.

[1]  J. García-Rodríguez,et al.  Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum. , 1978, Tubercle.

[2]  P. T. Sugihara,et al.  EXPERIMENTAL DRUG STUDIES ON MYCOBACTERIUM FORTUITUM. , 1964, Antimicrobial agents and chemotherapy.

[3]  M. Casal,et al.  In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin. , 1982, Tubercle.

[4]  R. Wallace,,et al.  In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria. , 1982, Reviews of infectious diseases.

[5]  W. Lester,et al.  In vitro susceptibility of mycobacteria to rifampin. , 1969, The American review of respiratory disease.

[6]  R. Wallace,,et al.  Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents , 1979, Antimicrobial Agents and Chemotherapy.

[7]  M. Cynamon,et al.  In vitro susceptibility of Mycobacterium fortuitum to cefoxitin , 1981, Antimicrobial Agents and Chemotherapy.

[8]  M. Casal,et al.  In vitro susceptibility of Mycobacterium fortuitum and M. chelonei to sisomicin, gentamicin and tobramycin. , 1983, Annales de microbiologie.

[9]  M. Cynamon,et al.  In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins , 1982, Antimicrobial Agents and Chemotherapy.

[10]  R. Good,et al.  Spectrum of disease due to rapidly growing mycobacteria. , 1983, Reviews of infectious diseases.

[11]  R. Wallace,,et al.  Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics , 1983, Antimicrobial Agents and Chemotherapy.

[12]  R. Wallace,,et al.  Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. , 1981, Reviews of infectious diseases.

[13]  M. Cynamon,et al.  In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid , 1983, Antimicrobial Agents and Chemotherapy.

[14]  G. Pankey,et al.  Problems in diagnosis and therapy of Mycobacterium fortuitum infections. , 1978, The American review of respiratory disease.

[15]  C. Thornsberry,et al.  Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution , 1982, Antimicrobial Agents and Chemotherapy.

[16]  W. Sanders,et al.  Susceptibility of Organisms in the Mycobacterium fortuitum Complex to Antituberculous and Other Antimicrobial Agents , 1977, Antimicrobial Agents and Chemotherapy.

[17]  R. Good,et al.  Identification of clinically significant Mycobacterium fortuitum complex isolates , 1981, Journal of clinical microbiology.

[18]  M. Daffé,et al.  Identification of Mycobacterium fortuitum and Mycobacterium chelonei , 1983, Journal of clinical microbiology.

[19]  R. Wallace,,et al.  Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei. , 1981, Reviews of infectious diseases.

[20]  W. Sanders,et al.  Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice. , 1971, The Journal of infectious diseases.

[21]  G. Pankey,et al.  In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. , 1978, The Journal of infectious diseases.